DRUG-INDUCED APOPTOSIS IS ASSOCIATED WITH ENHANCED FAS (APO-1 CD95) LIGAND EXPRESSION BUT OCCURS INDEPENDENTLY OF FAS (APO-1/CD95) SIGNALING IN HUMAN T-ACUTE LYMPHATIC-LEUKEMIA CELLS/
A. Villunger et al., DRUG-INDUCED APOPTOSIS IS ASSOCIATED WITH ENHANCED FAS (APO-1 CD95) LIGAND EXPRESSION BUT OCCURS INDEPENDENTLY OF FAS (APO-1/CD95) SIGNALING IN HUMAN T-ACUTE LYMPHATIC-LEUKEMIA CELLS/, Cancer research, 57(16), 1997, pp. 3331-3334
Induction of apoptosis is considered to be the underlying mechanism th
at accounts for the efficiency of chemotherapeutic drugs. It has recen
tly been proposed that induction of Fas ligand (FasL) expression with
subsequent autocrine and/or paracrine induction of cell death through
binding to the Fas (Apo-1/CD95) membrane accounts for chemotherapy-ass
ociated apoptosis. In the present study, me analyzed the significance
of Fast expression in the mediation of drug-induced apoptosis in the T
-acute lymphatic leukemia model CEM. In particular, me examined the po
tential of the tumor drugs fludarabine, doxorubicin, and cisplatin to
induce FasL expression. We also raised the question of whether apoptos
is induced by these drugs occurs through the Fas pathway and hence can
be blocked by the cowpox virus protein CrmA, a specific inhibitor of
this pathway, All tumor drugs examined led to an increase in FasL prot
ein. However, overexpression of CrmA had no effect on drug-induced apo
ptosis. Moreover, neither incubation with inhibitory monoclonal antibo
dies against Fas that completely prevented Fas-induced apoptosis in th
ese cells nor pretreatment with a monoclonal antibody to FasL affected
drug-induced cell death, Our observations suggest a Fas/FasL-independ
ent mechanism for drug-induced apoptosis and exclude the involvement o
f caspase 1 and caspase 8 in this process in T-acute lymphatic leukemi
a cells.